Medicines in Development for Alzheimer's Disease 2017 Report

America’s biopharmaceutical research companies are investigating or developing 85 medicines to help the more than five million patients in the United States who are living with Alzheimer’s.

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.